Induction of estrus during the non-breeding season in Egyptian Baladi goats

The induction of estrus during the non-breeding season was investigated in 100 Egyptian Baladi goats (Capra hircus). All animals assigned to treatments had low progesterone concentrations (<0.5 ng/ml) tested 2 times 10 days apart to confirm anestrous condition. Animals were assigned to three experimental groups. A group of animals received subcutaneous norgestomet ear implant for 11 days and a single i.m. injection of PGF2alpha 24 hr before implant removal (group I; n=40). Second group of animals received subcutaneous norgestomet ear implant for 11 days and a single i.m. injection of PGF2alpha 24 hr before implant removal and gonadotropin releasing hormone 24 hr after implant removal (group II; n=40). Third group of animals received no treatment (control group; n=20). The percentage of goats that showed estrous behavior during the first 72 hr after implant removal was 77.5, 85.0% and 10.0% in group I, group II and control group, respectively. The fertility rate was 57.5, 70.0% and 10.0% in group I, group II and control group, respectively. In conclusion, estrus can be induced in seasonally anestrous Egyptian Baladi goats using norgestomet and PGF2alpha and the injection of GnRH 24 hr after norgestomet implant removal synchronized ovulation in a higher percentage of goats.     

Reproductive performance in out-of-breeding season of fatty ewes using implant norgestomet with or without PMSG

Pregnancy in out-of-breeding season in ewes increases the economical goals. Synchronization of estrus and ovulation is essential for above program. The aims of this study using implant norgestomet with or without Pregnant Mare Serum Gonadotropin (PMSG) were to evaluate the serum progesterone (P4) concentration changes: the conception rate and estimation of the lambing rate and litter size. In total, 80 non-cycling multiparous Iranian Kurdish breed fat-tailed ewes with <0/5 ng/ml P4 were used in April and May 2008 in the suburb of Mashhad, Iran. The animals were randomly divided into three groups: a control group (n = 30) without hormonal treatment, another group (n = 25) received 3 mg of norgestomet implant placed subcutaneously in the convex surface of the ear for 9 days, and the third group (n = 25) treated with 3 mg of norgestomet implant for 9 days with an IM injection of 500 IU PMSG at implant removal. The progesterone of treatment and control groups were measured on days 4, 9, and 13 after removal of the norgestomet using radioimmunoassay. Every five ewes were exposed to one ram after 24 h of norgestomet removal in treatment and control groups, simultaneously. The pregnancy was examined after 25 days of ram removal using ultrasonography. Progesterone concentration was significantly higher in treatment groups on 9 and 13 days after norgestomet removal (P < 0.05). The pregnancy rate in the control, non-PMSG, and PMSG treatments groups were 17%, 52%, and 72%, respectively. The rates of single and twin pregnancy in the non-PMSG treatment group were 69% and 31%, respectively. These rates in norgestomet and PMSG treatment group were 50% and 39%, respectively. Triplet pregnancy (11%) was observed only in the PMSG treatment group. It was concluded that using implant norgestomet especially accompanied with PMSG can increase and improve the fertilization rate of ewe in the out-of-breeding season program.     

Calving rates in a tropical beef herd after treatment with a synthetic progestagen, norgestomet, or a prostaglandin analogue, cloprostenol

Maiden heifers and lactating cows of known ovarian status and of several breeds were treated with a synthetic prostaglandin, cloprostenol, or a synthetic progestagen, norgestomet, at the start of an artificial insemination (AI) program. Animals in the cloprostenol treatment received 2 injections 10 days apart. Over the next 26 days those animals that showed oestrous behaviour were inseminated. Synchronisation rates and calving rates to insemination over the first 7 days were calculated. Those in the norgestomet treatment received an implant of norgestomet plus an injection of norgestomet and oestradiol valerate. The implant was removed 10 days later and the animals were given an injection of pregnant mare serum gonadotrophin (PMSG). They were inseminated at 48 h (maiden heifers) or 56 h (lactating cows) after implant removal. Calving rates to fixed-time insemination were recorded. After completion of the AI program the animals in both treatments were joined with bulls. Overall calving rates (AI plus bulls) were calculated. By day 7 of the program, 82% of the maiden heifers and 76% of the lactating cows in the cloprostenol treatment had been detected in oestrus. By day 21 the respective figures were 99% and 81% Norgestomet treatment had an immediate and a prolonged effect on ovarian activity in those females classified as having inactive ovaries at the start of the AI program. Calving rates of those females to fixed-time AI and overall were similar to those of the females with active ovaries in both treatments. Their calving rates to fixed-time insemination, and overall calving rates for the lactating females, were significantly higher than the corresponding values of their contemporaries treated with cloprostenol and inseminated on observed oestrus over 7 days. For those females classified as having active ovaries at the start of the AI program, calving rates to first insemination and overall were similar for both treatments. Overall calving rates of lactating cows of each breed were, with one exception, higher in the norgestomet treatment than in the cloprostenol treatment. Although norgestomet treatment was more expensive than cloprostenol treatment, the advantage in calf crop resulted in an overall monetary advantage to the norgestomet treatment.     

A clinical trial using a regimen which includes a norgestomet implant and norgestomet plus oestradiol valerate injection as a treatment for anoestrus in dairy cows

In seasonally calving dairy herds in the Macalister Irrigation Area of Gippsland, Victoria, cows that had not been observed in oestrus by the start of the mating season and which had inactive ovaries based on rectal palpation and progesterone assay were treated with a hormonal treatment (n = 49). Mature cows had calved at least 40 days previously and 2-year-olds had been calved at least 60 days. The treatment consisted of a norgestomet implant and a norgestomet and oestradiol injection on day 1; prostaglandin analogue Prosolvin) on day 8; withdrawal of implant on day 10 and an injection of PMSG; and fixed time artificial insemination 54 to 56 h after implant withdrawal. This treatment was called the Syncro-mate regimen. Control cows (n = 46) were injected with water on days 1, 8 and 10 and artificially inseminated or served by a bull when seen on heat. Forty seven percent of the treated cows became pregnant within 14 days from the start of treatment compared with 20% of control cows (P less than 0.01). There was an effect of age group on the response to treatment. A greater proportion of 2-year-old cows than mature cows became pregnant within 14 days of treatment (79% of 19 v. 27% of 20; Chi square interaction, treatment by age, 6.4, P less than 0.05). In the younger cows there was also a gain of 22 days in the treatment to conception interval over the control cows (P less than 0.001). It was concluded that the Syncro-mate regimen can be an effective treatment for post partum anoestrus in dairy cows under certain conditions.     

Oestrus synchronisation and fertility in black Bengal goats following administration of progesterone/prostaglandin and gonadotrophins.

Oestrus synchronisation, fertility and kidding behaviour were studied in 44 Black Bengal goats. They were divided into six experimental groups: group 1, control; group 2, progesterone; group 3, progesterone, pregnant mare serum gonadotrophin (PMSG) and human chorionic gonadotrophin (HCG); group 4, prostaglandin F2 alpha (PGF2 alpha); group 5, PGF2 alpha, PMSG and HCG; group 6, PMSG and HCG. There was 100 per cent synchronisation of oestrus in the groups treated with progesterone, progesterone with PMSG and HCG, and prostaglandin with PMSG and HCG. In the other two treated groups the synchronisation was between 66 and 75 per cent. In the control group only 50 per cent of the animals came into oestrus during the period of observation. The duration of oestrus varied between 19 and 24 hours except in group 5 where it was 40.87 hours. Animals came on heat between 95 and 137 hours after treatment except in group 5 where the interval was only 18.87 hours. A maximum fertility of 75 per cent was observed in group 4 while the kidding percentage was greatest in group 2. There appeared to be no beneficial effect of superovulation on the number of kids produced. Gestation length was similar in all the groups.     

Impact of norgestomet supplementation during early luteal phase on subsequent luteal profiles and conception rate in buffalo: a preliminary study

The current study was aimed to establish the impact of progesterone supplementation (norgestomet progestagen) between days 4 to 10 post-ovulation on subsequent luteal profile and conception rate in buffaloes. The 28 Murrah buffaloes of second to fourth parity, having normal reproductive organs, were estrus synchronized by double PGF_2α protocol at 11 days apart. The buffaloes were inseminated during mid- to late estrus and thereafter repeated at 24 h interval. The buffaloes were randomly assigned into two groups: (1) control (no treatment, n?=?14) and (2) treatment group (CRESTAR ear implant, n?=?14). The CRESTAR ear implant (3 mg, norgestomet progestagen) was inserted subcutaneous between days 4 to 10 post-ovulation. The ovaries were scanned at estrus and thereafter on days 4, 10, 16, 21, and 40 post-ovulation to examine the preovulatory follicle (POF) and corpus luteum (CL) diameter. Each ultasonography was followed by blood sample collection for analysis of plasma progesterone concentrations following ovulation. The conception rate was similar (p?>?0.05) between treated and control buffaloes. The pregnant buffalo of the control group had larger (p?<?0.05) POF diameter than nonpregnant counterparts. The CL diameter was similar (p?>?0.05) in both treated and untreated control as well as in their pregnant and nonpregnant buffaloes of the respective groups. The plasma progesterone concentrations were higher (p?<?0.05) in the treatment group on the day 10 post-ovulation as compared to the control buffaloes. It is concluded that norgestomet supplementation had no impact on conception rate and CL diameter but enhances the plasma progesterone concentrations following treatment in buffaloes.     

Effect of feed treatment and exogenous estrogen and progestogen on puberty and lambing rates in ewe lambs

Four hundred seventy-four ewe lambs (5 to 6 mo of age) were assigned within breed to two postweaning feed treatments; 1 = alfalfa pellets ad libitum and 2 = alfalfa pellets plus 20% barley or wheat ad libitum. Ten days prior to the start of breeding, approximately one-half of the ewe lambs within each feed treatment were treated with a single injection of 2.5 mg of estradiol valerate and 1.5 mg of norgestomet and implanted with 3 mg of norgestomet for 8 d. At the start of breeding, fertile Suffolk rams were fitted with marking harnesses and penned with ewe lambs; evidence of estrus and breeding was determined on a weekly basis by visual examination for breeding marks. In the second year of the study, 7 to 13 d after recording estrous activity, all marked ewe lambs were bled; and blood was assayed for progesterone. In 1983, 60% of the ewe lambs showed estrus and 11% lambed compared with 48% exhibiting estrus and 30% lambing in 1984 (P less than .01). More (P less than .01) ewe lambs on feed treatment 1 displayed estrus, but more (P less than .05) lambed in the feed treatment 2 group. Steroid treatment resulted in more (P less than .01) ewe lambs showing estrus but fewer lambing (P less than .01). Examination of progesterone concentrations for evidence of ovulation and corpus luteum development indicated that treatment with steroids caused a large percentage of ewe lambs to exhibit estrus. However, many of these failed to develop a corpus luteum and become pregnant.(ABSTRACT TRUNCATED AT 250 WORDS)     

Effect of Oestrous Synchronization with Estradiol 17β and Progesterone on Follicular Wave Dynamics in Dairy Heifers

An experiment was designed to evaluate the effects of estradiol‐17β (E17β) on follicular wave dynamics and ovulatory response in Holstein heifers receiving either a progestogen ear‐implant (Crestar^®; Intervet International b.v. Boxmeer, The Netherlands) or an intravaginal progesterone‐releasing device [controlled internal drug release‐bovine device (Eazibreed, CIDR‐B^®; Bodinco BV, Alkmaar, The Netherlands)]. For comparison, another group of heifers was also synchronized using Crestar plus an injection of estradiol valerate (EV) and norgestomet as recommended by the pharmaceutical company. Twenty 20–22‐month‐old cycling Holstein heifers were allocated to one of the following treatment groups at random stages of the oestrous cycle: (I) simultaneous insertion of Crestar and intramuscular injection of 3 mg norgestomet and 5 mg EV (Crestar 9 + EV 9); (II) simultaneous insertion of Crestar and intramuscular injection of 5 mg E17β (Crestar 9 + E17β 9); (III) insertion of Crestar followed 2 days later by intramuscular injection of 5 mg E17β (Crestar 9 + E17β 7); or (IV) insertion of CIDR‐B device followed 2 days later by intramuscular injection of 5 mg E17β (CIDR 9 + E17β 7). The CIDR‐B or Crestar implants were removed after 9 days and all heifers received 500 μg Cloprostenol (Estrumate^®, Pitman‐Moore Nederland BV, Houten, The Netherlands). Ovarian ultrasonographic examinations were performed once daily during the synchronization period using a B‐mode scanner equipped with a 7.5 MHz linear‐array transrectal transducer. In addition, heifers were scanned every 12 h after implant/device withdrawal until 3 days after ovulation in order to monitor follicular activity, detect ovulation and subsequent early luteal formation. Detection of oestrus was performed every 6 h for 4 days after device/implant removal. Oestrus was observed 24–32 h before ovulation in all heifers. The mean hours interval from treatment withdrawal to ovulation was not significantly different (84.0 ± 16.5, 77.6 ± 4.1, 73.6 ± 4.1 and 64.0 ± 4.4 h for treatments I, II, III and IV, respectively; p > 0.1). However, the variance for heifers treated with EV + norgestomet was significantly larger (Levene’s Test; p < 0.01) than those treated with E17β. All E17β treatments resulted in dominant follicle suppression and a new wave emerged 4.1 days after treatment compared with 6.6 days for the EV + norgestomet treatment (p < 0.05). The time from emergence of the new ovulatory wave to ovulation was longer for the new wave that emerged after E17β treatment (9.2 ± 0.3 days) than after EV + norgestomet treatment (6.9 ± 0.4 days; p < 0.05). The results of this study suggest that the four treatments used were effective in inducing synchronous behavioural oestrus and ovulation. However, a higher degree of oestrus and ovulation synchrony was observed in heifers treated with E17β than in heifers treated with EV + norgestomet. Synchronization treatments with exogenous E17β or EV + norgestomet at the time of progestin device insertion (Crestar or CIDR‐B) or 2 days later in heifers can regulate a different emergence pattern of ovarian follicular development in randomly cyclic heifers. The E17β was effective in inducing follicular suppression and resulted in the consistent emergence of a new follicular wave.     

Timing the mating of dogs on the basis of blood progesterone concentration

The optimal time for mating bitches was determined by measuring the progesterone concentration in peripheral blood three times a week after the start of vulval bleeding. Of 104 bitches with reduced fertility 81 (78 per cent) became pregnant and of 112 bitches with normal fertility 105 (94 per cent) became pregnant. Of 121 bitches mated once, 102 (84 per cent) became pregnant, and of 95 bitches mated more than once, 84 (88 per cent) became pregnant. The mean (+/- sd) interval between the start of vulval bleeding and the optimal time for mating in 88 bitches was 11.8 +/- 3.1 days. The blood progesterone concentration appears to be an excellent indicator of the best time for mating, particularly in bitches with reduced fertility.     

Conclusions on the use of Suisychron in the USSR

Suisynchron was applied to 2,258 gilts, including 850 from breeding farms. Forty-four pigs were checked to elucidate the influence of sexual maturity on the success of oestrus synchronisation. Suisynchron-Pr?mix was fed to the animals over 20 days, the daily dose for each pig having been 5 g. Twenty-four hours were allowed to elapse from the last administration before 1,500 I.U. PMSG were injected. Synchronised oestrus occurred in 81.2 per cent of all pigs between four and six days from serum injection.Fertilisation in response to first insemination was recorded from 72.9 percent of the pigs, their fertility rate being 9.7 piglets from each farrowing sow. The results of oestrus synchronisation obtained from fattening pigs were somewhat inferior to those recorded from pigs of breeding units. Suisynchron and serum of pregnant mares can synchronise oestrus in 91 per cent of all mateable sows with no previous cycle. The fertility rates recorded from such pigs did not exceed 59 per cent or were between 28.9 and 31.9 per cent lower than those recordable from pigs with a cycle history prior to the use of Suisynchron.     

Oestrous cycles, oestrus and ovulation of the zebu in the Mexican tropics

The length of the oestrous cycle, oestrus and the time of ovulation were assessed in 20 adult, non-lactating zebu cows over 53 consecutive days of observation. Oestrus was detected at 30-minute observation periods daily. Peripheral blood samples were collected twice weekly for progesterone determination. To measure the length of the synchronised oestrous period, 10 cows with a palpable corpus luteum were injected with prostaglandin F2 alpha and continuously observed for 96 hours. Two cows at a time were exposed to a bull with a deviated penis for five minutes every three hours during this period. To measure the length of the natural oestrus, eight of the 10 cows from the previous experiment were continuously observed from day 21 after prostaglandin injection. They were kept during the daytime in a field with two teaser bulls and at night in a cattle pen where they were exposed to a teaser bull every three hours. Oestrus was considered to occur when the cow stood to be mounted. Ovulation was detected by rectal palpation every three hours in five cows starting six hours after receptivity commenced until ovulation took place. The length of the oestrous cycle was 20.1 +/- 1.9 days; 20 per cent of the animals did not show oestrus although their progesterone levels demonstrated that they were cycling. Two cows showed oestrus following prostaglandin F2 alpha injection although they were cycling as revealed by serum progesterone. Five animals showed behavioural oestrus around 118 hours after injection and following their release. Oestrus duration was 15.3 +/- 6.0 hours and ovulation occurred 28.2 +/- 5.0 hours after the start of the period of sexual receptivity.     

Luteinizing hormone and progesterone concentrations and induction of estrus after use of norgestomet ear implants or constant infusion of gonadotropin-releasing hormone in anestrous, nonlactating dairy goats

Plasma luteinizing hormone and progesterone concentrations, time to onset of estrus, and pregnancy rates were determined in nonlactating anestrous does given 1 of 4 treatments: subcutaneous ear implants containing 3 mg of norgestomet for 9 days (NOR; n = 6); subcutaneous administration, using osmotic minipumps, of 250 ng of gonadotropin-releasing hormone (GnRH)/h for 48 hours (GnRH; n = 6); 3 mg of NOR for 9 days, followed immediately by 250 ng of GnRH/h for 48 hours (NOR + GnRH; n = 6); or no treatment (control; n = 6). During the 72-hour period after removal of NOR or insertion of GnRH pumps, 6 of 6, 0 of 6, 6 of 6, and 3 of 6 does were observed in estrus at a mean (+/- 13.8) hours in groups NOR, GnRH, NOR + GnRH, and control, respectively. Time from end of treatment to peak concentrations of luteinizing hormone were 56 +/- 4.0, 28 +/- 4.7, 34 +/- 4.3, and 41 +/- 9.7 hours (mean +/- SE) for NOR, GnRH, NOR +/- GnRH, and control, respectively. Peak concentrations of luteinizing hormone were significantly greater and occurred significantly later in does given NOR. Progesterone concentrations in does that became pregnant increased to concentrations greater than or equal to 1.0 ng/ml 3 to 5 days after breeding and remained high. Functional corpora lutea (CL) was found in 6 does that did not become pregnant, 1 CL was associated with pseudopregnancy and 1 CL was associated with ovulation prior to placement of the GnRH pumps. Functional CL failed to form in 10 of the 12 doses in groups GnRH and control.(ABSTRACT TRUNCATED AT 250 WORDS)     

Estrus synchronization in sheep with synthetic progestagens

Sixteen female sheep of Degua breed were assigned to receive either the full dose of norgestomet ear implant and injectable solution containing norgestomet and estradiol valerate (n = 8) or half the dose (n = 8). The ear implants were removed in both groups on day 12. All ewes received an intramuscular administration of 500 IU PMSG at implant withdrawal. Synchronized ewes were individually hand mated twice at 48 and 60 hours after implant removal. One ewe in each group however refused mating on both occasions. Pregnancy diagnosis was conducted by bimanual external palpation 90 to 100 days post mating. The conception rates (3/7, 42.85%) and (5/7, 71.42%) were recorded in the two treatment groups, respectively. All eight ewes lambed between 145 to 153 days post mating. In group I ewes carried only singletons (prolificity rate 1.0) whereas in group II two ewes delivered twins, producing 7 lambs with prolificity rate of 1.4 (N.S). From this preliminary investigation it appears that the lower dose of norgestomet ear implants offers better option for estrus synchronization accompanied by higher fertility.     

Out-of-season breeding of milk goats--the effect of light treatment,melatonin and breed

The purpose of this study was to evaluate the effectivity of melatonin in addition to light treatment (exposure to 2 hours of light during the night = a long-day photoperiod) to modify the breeding season of Saanen and cross-bred milk goats and to compare the difference between the breeds. Twenty-two Saanen and 22 cross-bred does were randomly divided into 3 treatment groups. Group 1 (controls) received no treatment, Group 2 received light treatment for 37 days and Group 3 received light treatment plus melatonin implants after the light treatment. After a further 35 days the 3 groups were brought together and a billy goat that had also been exposed to the extra light at night, had received a melatonin implant and had been isolated from the does during the treatment period, was introduced to the does for natural mating. Ultrasound scanning was used to diagnose pregnancy and all the pregnant goats kidded. Significantly more Saanen does compared to cross-bred does (P = 0.018) became pregnant and kidded after natural mating, when the group that received melatonin as well as light treatment was compared to the group that received light treatment only. Compared to light treatment only, the addition of melatonin to light treatment improved (P = 0.0028) conception after natural mating, in both the Saanen and the cross-bred does.     

Effect of melatonin on induction of estrous cycles in anestrous ewes

To examine the influence of melatonin on seasonality of reproduction, 97 multiparous Suffolk and Suffolk-cross ewes were randomly assigned to one of four treatment (TRT) groups in a 2 X 2 factorial arrangement. Treatments were as follows: 1) control (C); 2) melatonin (M); 3) progestogen (P) implant of norgestomet plus pregnant mare serum gonadotropin (PMSG) injection (P + PMSG) and 4) M plus TRT 3 (M + P + PMSG). From April 3 to June 24 an oral dose of 2 mg M was administered once daily at 1600 to each ewe in TRT groups M and M + P + PMSG. On April 30, ewes in groups P + PMSG and M + P + PMSG were implanted in the ear with 2 mg norgestomet for 13 d. Immediately following implant removal, each ewe was injected with 500 IU PMSG. Blood samples were collected from all ewes twice weekly from March 22 through June 24. Number of estrous cycles per ewe during the TRT period of 82 d (April 3 to June 24) was higher (P less than .05) for M + P + PMSG (2.1 +/- .2) than for C (.3 +/- .2), M (1.5 +/- .2) and P + PMSG (1.1 +/- .2). Control ewes had fewer (P less than .05) estrous cycles per ewe than either M or P + PMSG. Following the induced estrus, 40% of ewes in the M TRT had one estrous cycle; 32% had two or more cycles. For ewes treated with M + P + PMSG, 24% had one cycle, and 32% had two estrous cycles.(ABSTRACT TRUNCATED AT 250 WORDS)     

The milk progesterone test as an aid to the diagnosis of cystic ovaries in dairy cows

Two field trials were carried out by five experienced veterinary surgeons to evaluate the milk progesterone test as an aid to the differential diagnosis of cystic ovaries in dairy cows. Of 200 cystic cows, 71 per cent were diagnosed clinically as follicular and 29 per cent as luteal cases; 80 per cent of the cases occurred in the six winter months November to April. The progesterone assay indicated that the diagnosis was correct in 84 per cent of the follicular cases but only 54 per cent of the luteal cases. Seventy-four per cent of the confirmed cystic cases responded to treatment within two weeks according to milk progesterone tests and there were no significant treatment differences. Overall, 80 per cent of the cows became pregnant on average 38 days after treatment having received an average of 1.70 inseminations each. Milk yield data in the first trial indicated that the cystic cows were not significantly higher yielders than their herd-mates.     

Synchronization of estrus in beef cattle with norgestomet and estradiol valerate

Fifty-six cows received a norgestomet implant and an injection of norgestomet and estradiol valerate; half (n = 28) received 500 IU equine chorionic gonadotrophin (eCG) at implant removal, 9 d later. A third group (n = 25) received 2 doses of cloprostenol (500 micrograms) 11 d apart. Estrous rate was higher (P < 0.05) for cows given norgestomet and estradiol plus 500 IU eCG (75.0%) than for those receiving cloprostenol (44.0%); for those receiving norgestomet and estradiol alone, it was intermediate (67.8%). Pregnancy rates to artificial insemination (after estrus or timed) were higher (P < 0.05) for cows given norgestomet and estradiol than for those given cloprostenol (23 of 28, 82.1% vs 13 of 25, 52.0%), and intermediate (67.8%) for those given norgestomet and estradiol plus eCG. In a second experiment, for heifers treated with norgestomet and estradiol plus eCG (n = 15) or with 2 doses of cloprostenol (n = 16), estrous rates were 66.7% vs 56.2% (P > 0.5), ovulation rates were 100.0% vs 81.2% (P = 0.08), intervals from implant removal or cloprostenol treatment to estrus were 48.0 +/- 4.4 hours vs 61.3 +/- 7.0 hours (P = 0.12) and to ovulation were 70.4 +/- 4.4 hours vs 93.2 +/- 7.5 hours (P < 0.01), respectively; pregnancy rates were 41.7 and 35.7%, respectively (P > 0.5). Norgestomet and estradiol were as good as (heifers) or superior to (cows) a 2-dose cloprostenol regimen. In cows given norgestomet and estradiol, injecting eCG at implant removal did not significantly improve estrous or pregnancy rates.     

Failure of a single treatment with ivermectin to control sheep scab (Psoroptes ovis) on artificially infested sheep

Ivermectin at 200 micrograms/kg bodyweight given either as a single subcutaneous injection or as an oral drench failed to eradicate Psoroptes ovis from artificially infested sheep. The oral drench reduced the mite populations by 43 per cent within 24 hours but no further significant decline was recorded over 38 days. The subcutaneous injection reduced the mite populations by 90 per cent after 10 days but live P ovis were present on all the treated animals 84 days after treatment. The efficacy of treatment was less the higher the initial mite burden. The injection had no effect on clinical sheep scab, and the disease continued to progress despite the mite mortality.     

Progestin and prostaglandin for estrous synchronization in beef heifers

Seventy-eight Simmental-Angus-Hereford crossbred yearling heifers, in 1983, and 99 similar heifers, in 1984, were used to compare two estrous synchrony regimens. One treatment group (SMB) was synchronized using the commercially available Syncro-Mate-B procedure, which involved placing a norgestomet implant in the ear for 9 d and giving an injection of norgestomet and estradiol valerate at the time of implantation. A second group (PR + PG) was given a norgestomet implant (PR) for 7 d and a 5-mg injection of alfaprostol (PG) at implant removal. Percentage of heifers cycling during the synchronization period and percent conceiving in 5 d or 30 d were not different (P greater than .10) due to treatment. The interval from implant removal to onset of behavioral estrus was shorter (P less than .01) for the heifers treated with SMB than for the heifers treated with PR + PG (42.8 vs 58.0 h). The group treated with SMB had a more uniform synchrony of estrus than the group treated with PR + PG. The effect of day of the estrous cycle at implantation on hours to estrus after implant removal was determined by a regression analysis, which showed a linear response for the SMB group with a slope of .78 (P = .09); the PR + PG group regression was cubic (P less than .01); this also indicated a more uniform response by the SMB group. These results indicate that the combination of norgestomet and alfaprostol produced more variation in interval from treatment to estrus than the Syncro-Mate-B procedure.(ABSTRACT TRUNCATED AT 250 WORDS)     

Efficacy of nitenpyram as a systemic flea adulticide in dogs and cats

In a clinical trial involving 123 cats and 88 dogs, the efficacy of tablets containing nitenpyram against natural flea infestations was investigated. The animals were selected from the routine cases of nine veterinary clinics in the UK and 143 were treated with the tablets and 68 control animals were treated with placebo tablets. Each animal was maintained in an individual cage. The time when the first fleas fell off each animal was recorded between 30 minutes and five hours after treatment, and six hours after treatment the numbers of live, moribund or dead fleas on each animal were determined, and the flea survival rate was calculated. The drug's efficacy was assessed by comparing the mean survival rates of fleas on the treated and control animals. Fleas started to fall from the animals 30 minutes after treatment and two hours after treatment some fleas had detached from 81 per cent of the treated animals. After six hours the efficacy of the drug reached 96.7 per cent on dogs and 95.2 per cent on cats, and 85.9 per cent of the fleas were found off the treated animals, compared with 1.8 per cent in the controls. No adverse drug reactions were recorded during the trial.